The biggest story in moringa leaf powder this year is not a demand curve. It is a food safety problem that has already changed who buys from whom. Four separate multistate Salmonella investigations tied to imported moringa leaf powder and moringa capsules have moved through the US market since October 2025. Counted across the four, they account for roughly 174 confirmed illnesses and 49 hospitalizations, with no deaths reported. Buyers who came through the year intact are the ones now asking for third-party pathogen testing, a validated kill step, and single-lot documentation before a shipment clears their dock.
Four investigations, one ingredient
The first case opened in October 2025. FDA traced a Salmonella Richmond outbreak to a single lot of organic moringa leaf powder, batch VFD/ORG/MORP/L/24 with a best-by date of November 2027, supplied by Vallon Farmdirect PVT LTD of Jodhpur, India. Eleven people in seven states fell ill and three were hospitalized, with illness onsets running from May 12 to September 4, 2025. The recalls covered Member’s Mark Super Greens sold at Sam’s Club, Food To Live organic moringa powder sold through Amazon, Walmart, Target, Etsy and eBay, and Africa Imports organic moringa leaf powder. CDC declared that outbreak over on December 4, 2025, according to FDA’s outbreak advisory.
The largest investigation opened on January 14, 2026, around Live it Up Super Greens powder from Superfoods, Inc. It grew to take in Why Not Natural moringa capsules from Art Monkey LLC and, later, TNVitamins and Doctor’s Pride capsules from Total Nutrition Inc. of Deer Park, New York. FDA closed it on March 17, 2026, at 97 illnesses across 32 states and 26 hospitalizations. Twenty-two new illnesses in four more states forced a reopening on May 27, pushing the count to 119 illnesses across 36 states and 32 hospitalizations. Of 79 people interviewed, 70, or 89 percent, reported eating a product containing moringa leaf powder before getting sick. That investigation is still open, per FDA.
The third case is the one that should worry a quality lead most. Rosabella-brand moringa capsules from Ambrosia Brands LLC carried Salmonella Newport and Salmonella Kentucky strains that were resistant to every first-line and alternative antibiotic normally used to treat Salmonella infection. Ten people in eight states fell ill and three were hospitalized, with onsets from September 26, 2025 to January 8, 2026. Ambrosia recalled on February 13, 2026. FDA traced the affected powder to a single supplier but never established a root cause, Food Safety Magazine reported when the investigation closed. The capsules had already reached 76 countries plus the United States and its territories, Food Safety News found.
The fourth closed on July 17, 2026. Salmonella Typhimurium tied to MOGO-brand Pure Moringa Oleifera capsules from MOGO Moringa LLC of St. Louis reached 34 illnesses across 14 states with 11 hospitalizations, with onsets from August 27, 2025 to June 21, 2026. MOGO sourced all of its moringa leaf powder from India. FDA sent investigators to both the ingredient supplier and the manufacturer, and issued observations citing deficiencies at both facilities, according to the agency.
What regulators have actually done
One thing has changed at the border. FDA said on July 17, when it closed the MOGO investigation, that it has increased screening of imported moringa powder from India for Salmonella. That is a real cost for anyone shipping from the dominant origin: more holds, more sampling, more days between arrival and release.
Trade groups expect the scrutiny to widen. Daniel Fabricant, chief executive of the Natural Products Association, told NutraIngredients that the pattern lines up with FDA’s own language about inadequate drying and the absence of validated kill steps in moringa production. “That really seems to be what’s consistent in some of the language reflected in FDA documents,” he said. Cara Welch, who runs FDA’s Office of Dietary Supplement Programs, framed the agency’s task plainly: “We need to understand how this happened and what we can do to stop it from happening again.” The Council for Responsible Nutrition has argued that a product registry covering higher-risk ingredients would speed traceback, and the American Herbal Products Association says it is collecting industry information on how to identify and monitor microbial levels in moringa.
None of that is abstract for a buyer. Redundant certificates of analysis, third-party pathogen testing and slower customs clearance all land in the same place, which is landed cost.
Price runs on two tracks
Origin pricing for moringa leaf powder is split hard by certification. Conventional powder trades at roughly USD 3.50 to 6.00 per kilogram FOB. Organic-certified powder runs USD 8.00 to 30.00 per kilogram FOB, according to the moringa market entry guide from CBI, the Netherlands government’s trade promotion body.
European buyer specs sit on top of that price. CBI reports the working baseline as moisture content of 8 to 10 percent, lead below 3.0 mg/kg, cadmium below 1.0 mg/kg, mercury below 0.1 mg/kg, and ISO 22000 or FSSC 22000 certification at the plant. Organic is no longer a premium tier so much as an entry ticket. “Without the organic certification I don’t think you’re really able to compete,” one German importer told CBI.
Who is buying
Supplement powders and capsules dominate moringa purchasing, which is exactly the segment the outbreaks hit. In the largest investigation, 70 of the 79 people interviewed reported eating a product containing moringa leaf powder, and most named a single greens powder brand.
Demand has not gone quiet. Kuli Kuli Foods, one of the longest-running mainstream US moringa brands, launched Pure Organic Moringa Capsules on January 15, 2026, with two capsules delivering more than 1,000 mg of organic moringa leaf powder, priced from $19.99 for a 30-day supply at KuliKuliFoods.com, Sprouts and Vitamin Shoppe, according to the company’s launch announcement. Private label is exposed too. Sam’s Club’s Member’s Mark house brand was pulled in the first outbreak, a reminder that retail scale did not insulate a large buyer from a gap at the supplier’s dryer.
Supply is moving away from one origin
India supplies an estimated 80 percent of the world’s moringa, per CBI, and that concentration is the reason a processing failure at origin turns into a nationwide recall in the United States. Diversification was already underway before the outbreaks. CBI reports that ethylene oxide residue findings in Indian shipments, layered on disagreements between India and the EU over certification standards, have pushed some Indian exporters to redirect volume toward the US market instead. European buyers have looked at South Africa as a pricier but more consistent alternative, with earlier-stage supply developing in Ghana, Kenya, Mozambique and Zambia.
Two facts sit awkwardly together here. No investigation has named a country of origin other than India. No investigation has named a single processor either. Buyers who switch origins to buy down risk are moving to supply bases that are younger, smaller, and in most cases have never been tested by a US recall.
What the EU will and will not accept
Anyone routing product into Europe should settle the category question before signing. Moringa oleifera leaf is not a Novel Food in the EU because of documented traditional use before 1997. Moringa stenopetala, sometimes sold as African moringa, has been shut out of that same route since the European Food Safety Authority raised unresolved safety objections in September 2019. EU rules separately keep moringa out of herbal medicinal products, and keep moringa seed oil out of food supplements. An exporter in Ghana or Kenya who assumes the Indian playbook transfers intact will find that it does not.
What it means for the rest of the year
The trade is not short of moringa. It is short of moringa with paperwork behind it. Four investigations in nine months have made the same point four times: the gap is not between good countries and bad countries, it is between lots that carry a validated kill step and traceable single-lot records and lots that do not. European importers are treating organic certification as the floor, tightening heavy-metal and microbial specs, and running trials with suppliers in South Africa, Ghana, Kenya, Mozambique and Zambia. For a trade built on thin margins and long lead times, documentation now decides a purchase order as firmly as price does.